78 related articles for article (PubMed ID: 8166242)
1. Modulation of intracellular calcium transients and dopamine release by neuropeptide Y in PC-12 cells.
Chen X; Westfall TC
Am J Physiol; 1994 Mar; 266(3 Pt 1):C784-93. PubMed ID: 8166242
[TBL] [Abstract][Full Text] [Related]
2. Regulation of neuropeptide Y release by neuropeptide Y receptor ligands and calcium channel antagonists in hypothalamic slices.
King PJ; Widdowson PS; Doods HN; Williams G
J Neurochem; 1999 Aug; 73(2):641-6. PubMed ID: 10428060
[TBL] [Abstract][Full Text] [Related]
3. Autoreceptor-induced inhibition of neuropeptide Y release from PC-12 cells is mediated by Y2 receptors.
Chen X; DiMaggio DA; Han SP; Westfall TC
Am J Physiol; 1997 Oct; 273(4):H1737-44. PubMed ID: 9362238
[TBL] [Abstract][Full Text] [Related]
4. K(+)-Evoked [(3)H]D-aspartate release in rat spinal cord synaptosomes: modulation by neuropeptide Y and calcium channel antagonists.
Martire M; Altobelli D; Maurizi S; Preziosi P; Fuxe K
J Neurosci Res; 2000 Dec; 62(5):722-9. PubMed ID: 11104511
[TBL] [Abstract][Full Text] [Related]
5. Neuropeptide Y Y2 receptor and somatostatin sst2 receptor coupling to mobilization of intracellular calcium in SH-SY5Y human neuroblastoma cells.
Connor M; Yeo A; Henderson G
Br J Pharmacol; 1997 Feb; 120(3):455-63. PubMed ID: 9031749
[TBL] [Abstract][Full Text] [Related]
6. Activation of neuropeptide Y Y1 receptors inhibits glutamate release through reduction of voltage-dependent Ca2+ entry in the rat cerebral cortex nerve terminals: suppression of this inhibitory effect by the protein kinase C-dependent facilitatory pathway.
Wang SJ
Neuroscience; 2005; 134(3):987-1000. PubMed ID: 16026936
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of dopamine mediated inhibition of neuropeptide Y release from pheochromocytoma cells (PC12 cells).
Cao G; Gardner A; Westfall TC
Biochem Pharmacol; 2007 May; 73(9):1446-54. PubMed ID: 17286966
[TBL] [Abstract][Full Text] [Related]
8. Endothelin (ET)-1-induced inhibition of ATP release from PC-12 cells is mediated by the ETB receptor: differential response to ET-1 on ATP, neuropeptide Y, and dopamine levels.
Gardner A; Westfall TC; Macarthur H
J Pharmacol Exp Ther; 2005 Jun; 313(3):1109-17. PubMed ID: 15687374
[TBL] [Abstract][Full Text] [Related]
9. Neuropeptide Y inhibition of calcium channels in PC-12 pheochromocytoma cells.
McCullough LA; Egan TM; Westfall TC
Am J Physiol; 1998 May; 274(5):C1290-7. PubMed ID: 9612216
[TBL] [Abstract][Full Text] [Related]
10. A pertussis toxin-insensitive calcium influx mediated by neuropeptide Y2 receptors in a human neuroblastoma cell line.
Lynch JW; Lemos VS; Bucher B; Stoclet JC; Takeda K
J Biol Chem; 1994 Mar; 269(11):8226-33. PubMed ID: 8132547
[TBL] [Abstract][Full Text] [Related]
11. Neuropeptide Y inhibits spontaneous alpha-melanocyte-stimulating hormone (alpha-MSH) release via a Y(5) receptor and suppresses thyrotropin-releasing hormone-induced alpha-MSH secretion via a Y(1) receptor in frog melanotrope cells.
Galas L; Tonon MC; Beaujean D; Fredriksson R; Larhammar D; Lihrmann I; Jegou S; Fournier A; Chartrel N; Vaudry H
Endocrinology; 2002 May; 143(5):1686-94. PubMed ID: 11956150
[TBL] [Abstract][Full Text] [Related]
12. Neuropeptide Y (18-36) modulates chromaffin cell catecholamine secretion by blocking the nicotinic receptor ion channel.
Zheng J; Morrisett RA; Zhu J; Hexum TD
J Pharmacol Exp Ther; 1995 Aug; 274(2):891-7. PubMed ID: 7543575
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Ca2+ channel currents in human neuroblastoma (SH-SY5Y) cells by neuropeptide Y and a novel cyclic neuropeptide Y analogue.
McDonald RL; Vaughan PF; Beck-Sickinger AG; Peers C
Neuropharmacology; 1995 Nov; 34(11):1507-14. PubMed ID: 8606797
[TBL] [Abstract][Full Text] [Related]
14. Effects of differentiation on neuropeptide-Y receptors and responses in rat pheochromocytoma cells.
DiMaggio DA; Farah JM; Westfall TC
Endocrinology; 1994 Feb; 134(2):719-27. PubMed ID: 8299567
[TBL] [Abstract][Full Text] [Related]
15. Y2 receptors for neuropeptide Y are coupled to three intracellular signal transduction pathways in a human neuroblastoma cell line.
Shigeri Y; Fujimoto M
J Biol Chem; 1994 Mar; 269(12):8842-8. PubMed ID: 8132619
[TBL] [Abstract][Full Text] [Related]
16. Neuropeptide Y regulates rat renal tubular Na,K-ATPase through several signalling pathways.
Ohtomo Y; Ono S; Zettergren E; Sahlgren B
Acta Physiol Scand; 1996 Sep; 158(1):97-105. PubMed ID: 8876753
[TBL] [Abstract][Full Text] [Related]
17. Neuropeptide Y modulates effects of bradykinin and prostaglandin E2 on trigeminal nociceptors via activation of the Y1 and Y2 receptors.
Gibbs JL; Diogenes A; Hargreaves KM
Br J Pharmacol; 2007 Jan; 150(1):72-9. PubMed ID: 17143304
[TBL] [Abstract][Full Text] [Related]
18. Y1 receptors for neuropeptide Y are coupled to mobilization of intracellular calcium and inhibition of adenylate cyclase.
Aakerlund L; Gether U; Fuhlendorff J; Schwartz TW; Thastrup O
FEBS Lett; 1990 Jan; 260(1):73-8. PubMed ID: 2153577
[TBL] [Abstract][Full Text] [Related]
19. Neuropeptide Y stimulates luteinizing hormone-releasing hormone release from superfused hypothalamic GT1-7 cells.
Besecke LM; Wolfe AM; Pierce ME; Takahashi JS; Levine JE
Endocrinology; 1994 Oct; 135(4):1621-7. PubMed ID: 7925125
[TBL] [Abstract][Full Text] [Related]
20. Neuropeptide Y Y2 receptor signalling mechanisms in the human glioblastoma cell line LN319.
Grouzmann E; Meyer C; Bürki E; Brunner H
Peptides; 2001 Mar; 22(3):379-86. PubMed ID: 11287092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
